Cislini Jeff 4
4 · Revolution Medicines, Inc. · Filed Nov 8, 2024
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$36.57/sh+6,000$219,420→ 51,634 total - Sale
Common Stock
2024-11-06$60.00/sh−6,000$360,000→ 45,634 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-06−6,000→ 30,000 totalExercise: $36.57From: 2024-06-15Exp: 2030-06-16→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024.
- [F2]Includes 40,209 restricted stock units.